-
Aaron Donald ends retirement to rejoin Rams: team
-
FIFA president Infantino 'must go', says ex-UEFA boss Platini
-
Niamey back to normal after soldiers' mutiny
-
England v Pakistan second Test: Three talking points
-
Niger mutiny suppressed, but questions remain over junta's cohesion
-
Rashford's return 'fantastic' for Man Utd, says Carrick
-
Como spoil Allegri's Napoli home debut
-
At least 8 die, more missing, as ferry capsizes off Northern Cyprus
-
Cruz Beckham Performs at Leeds Festival Following Family Support at Reading
-
Pegula shakes off nerves, Ruse in US Open first-round win
-
Fernandes hat-trick inspires Man Utd rout of Ipswich
-
Fernandes treble inspires Man Utd rout, Chelsea beat Brighton in thriller
-
Suzuki sends 'perfect' Freiburg past Bremen, Schalke lose
-
Android photo recovery depends on recently deleted folders
-
Instagram offers three routes to two-factor authentication
-
Realme P4s, iQOO Z11 and Nothing Phone 4b compared
-
September smartphone calendar spans Apple, Poco, Vivo and Xiaomi
-
Forest defender Tyler Bindon joins Charlton on loan
-
Eight dead and 23 missing after ferry sinks off Cyprus
-
Forest linked with Liverpool goalkeeper Mamardashvili
-
Russell Hobbs dual air fryer discounted to £99
-
Former Nottingham hospital chief linked to NHS training firm
-
British woman dies after stabbing at German station
-
UK clocks return to GMT on October 25
-
Beeston pub closes after office fire injures man
-
Data-centre opposition crosses US party lines
-
South West Water ranks worst in environmental comparison
-
Brighton swimmers adjust routines around sewage alerts
-
CERN creates quark-gluon plasma with smaller atomic nuclei
-
Practical boundaries can reduce group-chat overload
-
WIRED tests label makers for home organisation
-
Screen-free fitness bands gain ground as users seek fewer alerts
-
Google Maps adopts Lake America label for US users
-
Robinson strikes again as England wrap up Pakistan series win
-
Bellingham, Mbappe fire as Real Madrid ease to Malaga win
-
Red-hot Chelsea not the finished article says Alonso
-
Mas wins Vuelta 9th stage to extend lead
-
Dortmund's Konstantelias to miss 'several months' with knee injury
-
Robinson strikes as England close in on series win over Pakistan
-
Chelsea beat Brighton in seven-goal thriller, Leeds hold Brentford
-
Chelsea beat Brighton in seven-goal thriller to extend Alonso's perfect start
-
At least seven die in ferry capsize off Northern Cyprus; 23 missing
-
Zambia's opposition leader charged with treason
-
In-form Marc Marquez wins Aragon MotoGP Grand Prix
-
Marc Marquez wins Aragon MotoGP Grand Prix
-
At least six die in ferry capsize off Northern Cyprus
-
Robinson rocks Pakistan again as England eye series win at Lord's
-
Niamey back to normal after soldier mutiny
-
Nepal rescuers advance towards trapped tunnel workers
-
King Haakon joins Norway memorials for Harald
US Justice Dept taking abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The decision by President Joe Biden's administration came just hours after an appeals court rejected moves to ban mifepristone outright, but imposed a series of measures restricting access to the pill.
Mifepristone, which was approved by the Food and Drug Administration (FDA) in 2000 and accounts for more than half the abortions in the United States, has become the centerpiece of the country's latest clash over women's reproductive freedom.
Attorney General Merrick Garland said the Justice Department will be "seeking emergency relief from the Supreme Court to defend the FDA's scientific judgment and protect Americans' access to safe and effective reproductive care."
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone, also known as RU 486, should remain available pending a full hearing of the case, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the FDA's two-decades old approval of the drug last Friday.
- 'Furious' -
The appeals court said anti-abortion opponents had waited too long to challenge the drug's approval by the FDA but the judges' decision to impose restrictions on its use was denounced by groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
The anti-abortion group Susan B. Anthony described the appeals court ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over abortion rights comes nearly a year after the Supreme Court, where conservatives wield a 6-3 majority, overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
- 'Unborn human' -
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, seeking to impose a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
The Biden administration and leading pharmaceutical and biotech companies also argued that Kacsmaryk's ruling risked undermining the entire drug approval authority of the FDA.
"If this decision stands, no medication -- from chemotherapy drugs, to asthma medicine, to blood pressure pills, to insulin -- would be safe from attacks," said Vice President Kamala Harris.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access to the procedure -- or ban it outright.
L.E.Campos--PC